DOCSLIB.ORG

Doctoral Dissertation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

UNIVERSITY OF COPENH AGEN FACULTY OF HEALTH A ND MEDICAL SCIENCES Doctoral Dissertation Kirstine Callø The Transient Outward Potassium Current in Healthy and Diseased Hearts December 2017 The Faculty of Health and Medical Sciences at the University of Copenhagen has accepted this dissertation, which consists of the already published dissertations listed below, for public defence for the doctoral degree in Veterinary Science. Copenhagen, 24th of October 2018. Professor Ulla Wewer, Dean Public defence will be held in auditorium A1-05.01, Dyrlægevej 100, Frederiksberg Campus, University of Copenhagen, Friday 11th of January 2019 at 1 p.m. Kirstine Callø Section for Anatomy, Biochemistry and Physiology Department of Veterinary and Animals Sciences Faculty of Health and Medical Sciences University of Copenhagen [email protected] Copenhagen 30.12.2018 ISBN 978-87-971049-0-3 1 1 Contents 2 PUBLICATIONS..................................................................................................................... 3 3 PREFACE .............................................................................................................................. 4 3.1 Conflict of interests ........................................................................................................................................ 4 4 DANSK RESUMÉ................................................................................................................... 5 5 SUMMARY IN ENGLISH ........................................................................................................ 7 5.1 Abbreviations................................................................................................................................................. 9 5.2 Overview of cardiac currents and ion channel subunits ................................................................................10 5.3 Nomenclature ...............................................................................................................................................11 5.3.1 Currents ........................................................................................................................................................... 11 5.3.2 Ventricular layers ............................................................................................................................................ 11 6 INTRODUCTION - ELECTRICAL ACTIVITY OF THE HEART....................................................... 12 6.1 Aim and hypotheses......................................................................................................................................12 6.2 The electrocardiogram, ECG ..........................................................................................................................12 6.3 The cardiac conduction system .....................................................................................................................13 6.3.1 Purkinje networks ........................................................................................................................................... 14 6.4 The cardiac action potential and underlying ionic currents ...........................................................................16 6.4.1 Nodal action potentials ................................................................................................................................... 17 6.4.2 Atrial action potentials .................................................................................................................................... 18 6.4.3 Action potentials in the His-Purkinje system .................................................................................................. 19 6.4.4 Ventricular action potentials ........................................................................................................................... 20 6.5 Excitation-contraction ...................................................................................................................................21 6.6 Neurohumoral regulation .............................................................................................................................22 6.6.1 Sympathetic regulation of the heart ............................................................................................................... 23 6.6.2 Parasympathetic regulation of the heart ........................................................................................................ 24 7 REGIONAL HETEROGENEITY OF VENTRICULAR ACTION POTENTIAL MORPHOLOGY AND IMPLICATIONS FOR CARDIAC FUNCTION ................................................................................... 26 7.1 Transmural heterogeneity in early repolarization .........................................................................................26 7.2 The role of the transient outward potassium current in excitation-contraction coupling ..............................28 7.3 The transient outward potassium current, Ito ................................................................................................31 7.3.1 Molecular composition of Ito ........................................................................................................................... 31 7.3.2 Pharmacology of Ito,f ........................................................................................................................................ 32 7.3.3 The effect of Ito activators NS5806 and NS3623 on isolated canine ventricular cells ..................................... 33 7.4 Pathophysiological implications of Ito,f ..........................................................................................................37 7.4.1 Ito,f and cardiac arrhythmias ............................................................................................................................ 37 7.4.2 Ito,f in heart failure ........................................................................................................................................... 39 7.5 Is pharmaceutically increased Ito,f potentially beneficial in failing hearts? .....................................................42 8 CONCLUDING REMARKS AND FUTURE PERSPECTIVES ........................................................ 45 8.1 The physiological significance of the Purkinje fibre distribution ....................................................................45 8.2 Is pharmaceutically increased Ito,f potentially beneficial in heart failure? ......................................................46 8.3 Methological considerations .........................................................................................................................47 8.4 Conclusion ....................................................................................................................................................48 9 ACKNOWLEDGEMENTS ...................................................................................................... 48 10 REFERENCES ................................................................................................................... 49 2 2 PUBLICATIONS The dissertation is based on the following publications: A dual potassium channel activator improves repolarization reserve and normalizes ventricular action potentials. Calloe K, Di Diego JM, Hansen RS, Nagle S, Treat JA, Cordeiro JM. Biochem Pharmacol. 2016 May 15;108:36-46 Tissue-specific effects of acetylcholine in the canine heart. Calloe K, Goodrow R, Antzelevitch C, Olesen SP, Cordeiro JM. Am J Physiol Heart Circ Physiol. 2013 Jul 1;305(1):H66-75. Physiological consequences of transient outward K+ current activation during heart failure in canine left ventricle. Cordeiro JM*, Calloe K*, Moise NS, Kornreich B, Giannandrea D, Diego JDM, Olesen SP, Antzelevitch C. J *Contributed equally. J Mol Cell Cardiol. 2012 Jun;52(6):1291-8. Comparison of the effects of a transient outward potassium channel activator on currents recorded from atrial and ventricular cardiomyocytes. Calloe K, Nof E, Jespersen T, Chlus N, Di Diego JM, Olesen SP, Antzelevitch C, Cordeiro JM. J Cardiovasc Electrophysiol. 2011 Sep;22(9):1057-66. Effect of the Ito activator NS5806 on cloned Kv4 channels depends on the accessory protein KChIP2. Lundby A, Jespersen T, Schmitt N, Grunnet M, Olesen SP, Cordeiro JM, Calloe K. British J of Pharmacol. 2010; 160(8):2028-44. Differential effects of the transient outward K+ current activator NS5806 in the canine left ventricle. Calloe K, Soltysinska E, Jespersen T, Lundby A, Antzelevitch C, Olesen SP, Cordeiro JM. J Mol Cell Cardiol. 2010; 48:191-200. A transient outward potassium current activator recapitulates the electrocardiographic manifestations of Brugada syndrome. Calloe K*, Cordeiro JM*, Di Diego JM, Hansen RS, Grunnet M, Olesen SP, Antzelevitch C. *Contributed equally. Cardiovasc Res. 2009; 81(4):686-94. Editorial comment: in Cardiovasc. Res. 2009, 81:635-636. 3 3 PREFACE The present thesis is based on studies performed at the Department of Veterinary and Animal Sciences (IVH) and the Department of Biomedical Sciences (BMI) at the University of Copenhagen (UCPH) and the Masonic Medical Research Laboratory (MMRL), Utica, NY, USA from 2008 to 2016. I wish to express my gratitude to Professor Dan A. Klærke for his enthusiasm and encouragement. His way of approaching and exploring new scientific ideas is very inspiring and constantly reminds me that science is fun. Thank you for being a true mentor.
Recommended publications
  • Towards Mutation-Specific Precision Medicine in Atypical Clinical

    Towards Mutation-Specific Precision Medicine in Atypical Clinical

    International Journal of Molecular Sciences Review Towards Mutation-Specific Precision Medicine in Atypical Clinical Phenotypes of Inherited Arrhythmia Syndromes Tadashi Nakajima * , Shuntaro Tamura, Masahiko Kurabayashi and Yoshiaki Kaneko Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi 371-8511, Gunma, Japan; [email protected] (S.T.); [email protected] (M.K.); [email protected] (Y.K.) * Correspondence: [email protected]; Tel.: +81-27-220-8145; Fax: +81-27-220-8158 Abstract: Most causal genes for inherited arrhythmia syndromes (IASs) encode cardiac ion channel- related proteins. Genotype-phenotype studies and functional analyses of mutant genes, using heterol- ogous expression systems and animal models, have revealed the pathophysiology of IASs and enabled, in part, the establishment of causal gene-specific precision medicine. Additionally, the utilization of induced pluripotent stem cell (iPSC) technology have provided further insights into the patho- physiology of IASs and novel promising therapeutic strategies, especially in long QT syndrome. It is now known that there are atypical clinical phenotypes of IASs associated with specific mutations that have unique electrophysiological properties, which raises a possibility of mutation-specific precision medicine. In particular, patients with Brugada syndrome harboring an SCN5A R1632C mutation exhibit exercise-induced cardiac events, which may be caused by a marked activity-dependent loss of R1632C-Nav1.5 availability due to a marked delay of recovery from inactivation. This suggests that the use of isoproterenol should be avoided. Conversely, the efficacy of β-blocker needs to be examined. Patients harboring a KCND3 V392I mutation exhibit both cardiac (early repolarization syndrome and Citation: Nakajima, T.; Tamura, S.; paroxysmal atrial fibrillation) and cerebral (epilepsy) phenotypes, which may be associated with a Kurabayashi, M.; Kaneko, Y.
  • Examining the Regulation of Kv7 K+ Channels in Airway Smooth Muscle Cells and Their Potential As Novel Therapeutic Targets for the Treatment of Asthma

    Examining the Regulation of Kv7 K+ Channels in Airway Smooth Muscle Cells and Their Potential As Novel Therapeutic Targets for the Treatment of Asthma

    Loyola University Chicago Loyola eCommons Dissertations Theses and Dissertations 2017 Examining the Regulation of Kv7 K+ Channels in Airway Smooth Muscle Cells and Their Potential as Novel Therapeutic Targets for the Treatment of Asthma Jennifer Haick Loyola University Chicago Follow this and additional works at: https://ecommons.luc.edu/luc_diss Part of the Pharmacology Commons Recommended Citation Haick, Jennifer, "Examining the Regulation of Kv7 K+ Channels in Airway Smooth Muscle Cells and Their Potential as Novel Therapeutic Targets for the Treatment of Asthma" (2017). Dissertations. 2588. https://ecommons.luc.edu/luc_diss/2588 This Dissertation is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons. It has been accepted for inclusion in Dissertations by an authorized administrator of Loyola eCommons. For more information, please contact [email protected]. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. Copyright © 2017 Jennifer Haick LOYOLA UNIVERSITY CHICAGO EXAMINING THE REGULATION OF Kv7 K+ CHANNELS IN AIRWAY SMOOTH MUSCLE CELLS AND THEIR POTENTIAL AS NOVEL THERAPEUTIC TARGETS FOR THE TREATMENT OF ASTHMA A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL IN CANDIDACY FOR THE DEGREE OF DOCTOR OF PHILOSOPHY PROGRAM IN MOLECULAR PHARMACOLOGY AND THERAPEUTICS BY JENNIFER HAICK CHICAGO, IL MAY 2017 ACKNOWLEDGEMENTS I would like to take a moment to thank all of the people who have helped and supported me these past years while I have been working towards my Ph.D. First and foremost, I would like to thank Dr. Kenneth Byron for accepting me into his lab and for his mentorship these past years.
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
  • Transcriptomic Analysis of Native Versus Cultured Human and Mouse Dorsal Root Ganglia Focused on Pharmacological Targets Short

    Transcriptomic Analysis of Native Versus Cultured Human and Mouse Dorsal Root Ganglia Focused on Pharmacological Targets Short

    bioRxiv preprint doi: https://doi.org/10.1101/766865; this version posted September 12, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. Transcriptomic analysis of native versus cultured human and mouse dorsal root ganglia focused on pharmacological targets Short title: Comparative transcriptomics of acutely dissected versus cultured DRGs Andi Wangzhou1, Lisa A. McIlvried2, Candler Paige1, Paulino Barragan-Iglesias1, Carolyn A. Guzman1, Gregory Dussor1, Pradipta R. Ray1,#, Robert W. Gereau IV2, # and Theodore J. Price1, # 1The University of Texas at Dallas, School of Behavioral and Brain Sciences and Center for Advanced Pain Studies, 800 W Campbell Rd. Richardson, TX, 75080, USA 2Washington University Pain Center and Department of Anesthesiology, Washington University School of Medicine # corresponding authors [email protected], [email protected] and [email protected] Funding: NIH grants T32DA007261 (LM); NS065926 and NS102161 (TJP); NS106953 and NS042595 (RWG). The authors declare no conflicts of interest Author Contributions Conceived of the Project: PRR, RWG IV and TJP Performed Experiments: AW, LAM, CP, PB-I Supervised Experiments: GD, RWG IV, TJP Analyzed Data: AW, LAM, CP, CAG, PRR Supervised Bioinformatics Analysis: PRR Drew Figures: AW, PRR Wrote and Edited Manuscript: AW, LAM, CP, GD, PRR, RWG IV, TJP All authors approved the final version of the manuscript. 1 bioRxiv preprint doi: https://doi.org/10.1101/766865; this version posted September 12, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
  • Investigation of Candidate Genes and Mechanisms Underlying Obesity

    Investigation of Candidate Genes and Mechanisms Underlying Obesity

    Prashanth et al. BMC Endocrine Disorders (2021) 21:80 https://doi.org/10.1186/s12902-021-00718-5 RESEARCH ARTICLE Open Access Investigation of candidate genes and mechanisms underlying obesity associated type 2 diabetes mellitus using bioinformatics analysis and screening of small drug molecules G. Prashanth1 , Basavaraj Vastrad2 , Anandkumar Tengli3 , Chanabasayya Vastrad4* and Iranna Kotturshetti5 Abstract Background: Obesity associated type 2 diabetes mellitus is a metabolic disorder ; however, the etiology of obesity associated type 2 diabetes mellitus remains largely unknown. There is an urgent need to further broaden the understanding of the molecular mechanism associated in obesity associated type 2 diabetes mellitus. Methods: To screen the differentially expressed genes (DEGs) that might play essential roles in obesity associated type 2 diabetes mellitus, the publicly available expression profiling by high throughput sequencing data (GSE143319) was downloaded and screened for DEGs. Then, Gene Ontology (GO) and REACTOME pathway enrichment analysis were performed. The protein - protein interaction network, miRNA - target genes regulatory network and TF-target gene regulatory network were constructed and analyzed for identification of hub and target genes. The hub genes were validated by receiver operating characteristic (ROC) curve analysis and RT- PCR analysis. Finally, a molecular docking study was performed on over expressed proteins to predict the target small drug molecules. Results: A total of 820 DEGs were identified between
  • Expression Profiling of Ion Channel Genes Predicts Clinical Outcome in Breast Cancer

    Expression Profiling of Ion Channel Genes Predicts Clinical Outcome in Breast Cancer

    UCSF UC San Francisco Previously Published Works Title Expression profiling of ion channel genes predicts clinical outcome in breast cancer Permalink https://escholarship.org/uc/item/1zq9j4nw Journal Molecular Cancer, 12(1) ISSN 1476-4598 Authors Ko, Jae-Hong Ko, Eun A Gu, Wanjun et al. Publication Date 2013-09-22 DOI http://dx.doi.org/10.1186/1476-4598-12-106 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Ko et al. Molecular Cancer 2013, 12:106 http://www.molecular-cancer.com/content/12/1/106 RESEARCH Open Access Expression profiling of ion channel genes predicts clinical outcome in breast cancer Jae-Hong Ko1, Eun A Ko2, Wanjun Gu3, Inja Lim1, Hyoweon Bang1* and Tong Zhou4,5* Abstract Background: Ion channels play a critical role in a wide variety of biological processes, including the development of human cancer. However, the overall impact of ion channels on tumorigenicity in breast cancer remains controversial. Methods: We conduct microarray meta-analysis on 280 ion channel genes. We identify candidate ion channels that are implicated in breast cancer based on gene expression profiling. We test the relationship between the expression of ion channel genes and p53 mutation status, ER status, and histological tumor grade in the discovery cohort. A molecular signature consisting of ion channel genes (IC30) is identified by Spearman’s rank correlation test conducted between tumor grade and gene expression. A risk scoring system is developed based on IC30. We test the prognostic power of IC30 in the discovery and seven validation cohorts by both Cox proportional hazard regression and log-rank test.
  • Genome-Wide Association and Transcriptome Studies Identify Candidate Genes and Pathways for Feed Conversion Ratio in Pigs

    Genome-Wide Association and Transcriptome Studies Identify Candidate Genes and Pathways for Feed Conversion Ratio in Pigs

    Miao et al. BMC Genomics (2021) 22:294 https://doi.org/10.1186/s12864-021-07570-w RESEARCH ARTICLE Open Access Genome-wide association and transcriptome studies identify candidate genes and pathways for feed conversion ratio in pigs Yuanxin Miao1,2,3, Quanshun Mei1,2, Chuanke Fu1,2, Mingxing Liao1,2,4, Yan Liu1,2, Xuewen Xu1,2, Xinyun Li1,2, Shuhong Zhao1,2 and Tao Xiang1,2* Abstract Background: The feed conversion ratio (FCR) is an important productive trait that greatly affects profits in the pig industry. Elucidating the genetic mechanisms underpinning FCR may promote more efficient improvement of FCR through artificial selection. In this study, we integrated a genome-wide association study (GWAS) with transcriptome analyses of different tissues in Yorkshire pigs (YY) with the aim of identifying key genes and signalling pathways associated with FCR. Results: A total of 61 significant single nucleotide polymorphisms (SNPs) were detected by GWAS in YY. All of these SNPs were located on porcine chromosome (SSC) 5, and the covered region was considered a quantitative trait locus (QTL) region for FCR. Some genes distributed around these significant SNPs were considered as candidates for regulating FCR, including TPH2, FAR2, IRAK3, YARS2, GRIP1, FRS2, CNOT2 and TRHDE. According to transcriptome analyses in the hypothalamus, TPH2 exhibits the potential to regulate intestinal motility through serotonergic synapse and oxytocin signalling pathways. In addition, GRIP1 may be involved in glutamatergic and GABAergic signalling pathways, which regulate FCR by affecting appetite in pigs. Moreover, GRIP1, FRS2, CNOT2,andTRHDE may regulate metabolism in various tissues through a thyroid hormone signalling pathway.
  • Atrial Fibrillation (ATRIA) Study

    Atrial Fibrillation (ATRIA) Study

    European Journal of Human Genetics (2014) 22, 297–306 & 2014 Macmillan Publishers Limited All rights reserved 1018-4813/14 www.nature.com/ejhg REVIEW Atrial fibrillation: the role of common and rare genetic variants Morten S Olesen*,1,2,4, Morten W Nielsen1,2,4, Stig Haunsø1,2,3 and Jesper H Svendsen1,2,3 Atrial fibrillation (AF) is the most common cardiac arrhythmia affecting 1–2% of the general population. A number of studies have demonstrated that AF, and in particular lone AF, has a substantial genetic component. Monogenic mutations in lone and familial AF, although rare, have been recognized for many years. Presently, mutations in 25 genes have been associated with AF. However, the complexity of monogenic AF is illustrated by the recent finding that both gain- and loss-of-function mutations in the same gene can cause AF. Genome-wide association studies (GWAS) have indicated that common single-nucleotide polymorphisms (SNPs) have a role in the development of AF. Following the first GWAS discovering the association between PITX2 and AF, several new GWAS reports have identified SNPs associated with susceptibility of AF. To date, nine SNPs have been associated with AF. The exact biological pathways involving these SNPs and the development of AF are now starting to be elucidated. Since the first GWAS, the number of papers concerning the genetic basis of AF has increased drastically and the majority of these papers are for the first time included in a review. In this review, we discuss the genetic basis of AF and the role of both common and rare genetic variants in the susceptibility of developing AF.
  • Dynamic Subunit Stoichiometry Confers a Progressive Continuum of Pharmacological Sensitivity by KCNQ Potassium Channels

    Dynamic Subunit Stoichiometry Confers a Progressive Continuum of Pharmacological Sensitivity by KCNQ Potassium Channels

    Dynamic subunit stoichiometry confers a progressive continuum of pharmacological sensitivity by KCNQ potassium channels Haibo Yua,b, Zhihong Lina,b,1, Margrith E. Mattmannc,d,e, Beiyan Zoua,b, Cecile Terrenoiref, Hongkang Zhanga,b, Meng Wua,b,2, Owen B. McManusa,b, Robert S. Kassf, Craig W. Lindsleyc,d,e,g, Corey R. Hopkinsc,d,e,g,3, and Min Lia,b,3 aThe Solomon H. Snyder Department of Neuroscience, High Throughput Biology Center and bJohns Hopkins Ion Channel Center, Johns Hopkins University, Baltimore, MD 21205; cDepartment of Pharmacology and dVanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, TN 37232; gDepartment of Chemistry and eVanderbilt Specialized Chemistry Center for Probe Development, Vanderbilt University, Nashville, TN 37232; and fDepartment of Pharmacology, Columbia University College of Physicians and Surgeons, New York, NY 10032 Edited by Richard W. Aldrich, University of Texas at Austin, Austin, TX, and approved April 3, 2013 (received for review January 14, 2013) Voltage-gated KCNQ1 (Kv7.1) potassium channels are expressed represents an effective strategy to understand the physiological abundantly in heart but they are also found in multiple other tissues. roles of this current and may form a basis for development of Differential coassembly with single transmembrane KCNE beta sub- therapeutics for specific cardiac arrhythmias. units in different cell types gives rise to a variety of biophysical Several pharmacological gating modifiers of KCNQ1 have been properties, hence endowing distinct physiological roles for KCNQ1– reported. These include R-L3 (9, 10), zinc pyrithione (ZnPy) (11) KCNEx complexes. Mutations in either KCNQ1 or KCNE1 genes result and phenylboronic acid (PBA) (12).
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD

    Supplementary Table S4. FGA Co-Expressed Gene List in LUAD

    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
  • Ion Channels 3 1

    Ion Channels 3 1

    r r r Cell Signalling Biology Michael J. Berridge Module 3 Ion Channels 3 1 Module 3 Ion Channels Synopsis Ion channels have two main signalling functions: either they can generate second messengers or they can function as effectors by responding to such messengers. Their role in signal generation is mainly centred on the Ca2 + signalling pathway, which has a large number of Ca2+ entry channels and internal Ca2+ release channels, both of which contribute to the generation of Ca2 + signals. Ion channels are also important effectors in that they mediate the action of different intracellular signalling pathways. There are a large number of K+ channels and many of these function in different + aspects of cell signalling. The voltage-dependent K (KV) channels regulate membrane potential and + excitability. The inward rectifier K (Kir) channel family has a number of important groups of channels + + such as the G protein-gated inward rectifier K (GIRK) channels and the ATP-sensitive K (KATP) + + channels. The two-pore domain K (K2P) channels are responsible for the large background K current. Some of the actions of Ca2 + are carried out by Ca2+-sensitive K+ channels and Ca2+-sensitive Cl − channels. The latter are members of a large group of chloride channels and transporters with multiple functions. There is a large family of ATP-binding cassette (ABC) transporters some of which have a signalling role in that they extrude signalling components from the cell. One of the ABC transporters is the cystic − − fibrosis transmembrane conductance regulator (CFTR) that conducts anions (Cl and HCO3 )and contributes to the osmotic gradient for the parallel flow of water in various transporting epithelia.
  • 72X36 Poster Template

    72X36 Poster Template

    Circulating microRNA evaluated in the early aftermath of motor vehicle collision predict widespread pain development in African Americans and provide potential pathogenic insights: results of a preliminary analysis Linnstaedt S1,2, Walker M1,2, Parker J3, Sons RL4, Zinny E5, Lewandowski C5, Hendry PL6, Damiron K7 , Pearson C8, Velilla MA9, Jones J10, Domeier R11, Swor R12, Hammond SM4, McLean S1,2,13 From the 1TRYUMPH Research Program, 2Department of Anesthesiology, UNC-CH and 3Lineberger Comprehensive Cancer Center, UNC-CH; 4Department of Cell Biology and Physiology, UNC-CH; 5Department of Emergency Medicine Henry Ford Hospital; 6Department of Emergency Medicine Shands Jacksonville Medical Center; 7Department of Emergency Medicine Albert Einstein Medical Center; 8Department of Emergency Medicine Detroit Receiving; 9Department of Emergency Medicine Sinai Grace; 10Department of Emergency Spectrum Health-Butterworth Campus; 11 Department of Emergency Medicine St. Joseph Mercy Health System; 12Department of Emergency Medicine William Beaumont Hospital; 13Department of Emergency Medicine, UNC-CH INTRODUCTION FIGURE 1. Study sites and methods TABLE 1. Study characteristics RESULTS microRNA (miRNA) are small non-coding RNA molecules that regulate gene Participant characteristics are shown in Table 1. NGS resulted in an average of 9 expression by binding target mRNA. miRNA are highly stable in blood. Characteristic million sequencing reads per individual, 95% of which aligned to miRNA (Figure 1). Participants, n 75 During the past decade, the study of miRNA has transformed understanding of Fractionate miRNA, Age, yrs, mean (SD) 36 (12) Even in this small sample, 11 miRNA were expressed at significantly different levels in the regulation of major biological pathways and advanced understanding of the prepare for Females, n (%) 44 (58) AA who subsequently did and did not develop WP 6 weeks after MVC (Table 2).